Global Veterinary Intravenous (iv) Solutions Market Size & Outlook
Global veterinary intravenous (iv) solutions market, 2018-2030 (US$M)
Related Markets
Global veterinary intravenous (iv) solutions market highlights
- The global veterinary intravenous (iv) solutions market generated a revenue of USD 1,452.9 million in 2024 and is expected to reach USD 2,072.8 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 6.2% by 2030.
- In terms of segment, isotonic crystalloids accounted for a revenue of USD 652.1 million in 2024.
- Dextrose solutions is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 1,452.9 million |
| Market revenue in 2030 | USD 2,072.8 million |
| Growth rate | 6.2% (CAGR from 2025 to 2030) |
| Largest segment | Isotonic crystalloids |
| Fastest growing segment | Dextrose solutions |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition |
Other key industry trends
- In terms of revenue, the North America accounted for 38.1% of the global veterinary intravenous (iv) solutions market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 81.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Intravenous (IV) Solutions Market Scope
Veterinary Intravenous (IV) Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Fresenius Kabi | View profile | 10001+ | Bad Homburg, Hessen, Germany, Europe | https://www.fresenius-kabi.se |
| Woods Consulting | View profile | 1-10 | Dunedin, Florida, United States, North America | https://woodsconsulting.org |
| Sypharma | View profile | 51-100 | Dandenong, Victoria, Australia, Oceania | http://sypharma.com.au |
| Dechra Veterinary Products | View profile | - | Overland Park, Kansas, United States, North America | http://dechra-us.com |
| B. Braun | View profile | 10001+ | Chapeltown, Sheffield, United Kingdom, Europe | https://www.bbraun.co.uk |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Fresenius SE & Co KGaA | View profile | 193865 | Else-Kroener-Strasse 1, Bad Homburg, HE, Germany, 61352 | https://www.fresenius.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
Global veterinary intravenous (iv) solutions market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary intravenous (iv) solutions market will help companies and investors design strategic landscapes.
Isotonic crystalloids was the largest segment with a revenue share of 44.88% in 2024. Horizon Databook has segmented the Global veterinary intravenous (iv) solutions market based on isotonic crystalloids, synthetic colloids, blood products, dextrose solutions, parenteral nutrition covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Veterinary Intravenous (IV) Solutions Product Outlook (Revenue, USD Million, 2018-2030)
- Isotonic crystalloids
- Dextrose solutions
- Synthetic colloids
- Parenteral nutrition
- Blood products
- Global Veterinary Intravenous (IV) Solutions Indication Outlook (Revenue, USD Million, 2018-2030)
- Diabetic Ketoacidosis
- Others
- Pancreatitis
- Anthrax
- Chronic Kidney Disease
- Global Veterinary Intravenous (IV) Solutions Animal type Outlook (Revenue, USD Million, 2018-2030)
- Production Animals
- Companion Animals
- Global Veterinary Intravenous (IV) Solutions End Use Outlook (Revenue, USD Million, 2018-2030)
- Research Institutes
- Veterinary Hospitals
- Others
Reasons to subscribe to Global veterinary intravenous (iv) solutions market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global veterinary intravenous (iv) solutions market databook
-
Our clientele includes a mix of veterinary intravenous (iv) solutions market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global veterinary intravenous (iv) solutions market , including forecasts for subscribers. This global databook contains high-level insights into Global veterinary intravenous (iv) solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global veterinary intravenous (iv) solutions market size, by regions, 2018-2030 (US$M)
Top 10 countries: Veterinary intravenous (iv) solutions market size, 2024 (US$M)
Global veterinary intravenous (iv) solutions market share, by product, 2024 & 2030 (%, US$M)
Veterinary intravenous (iv) solutions market: Opportunity assessment by country
Global veterinary intravenous (iv) solutions market, by region, 2024 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
